Similar articles

• [Immunotherapy for allergic rhinitis induced by Japanese cedar pollens].

  Ohashi Y. Ohashi Y. Arerugi. 2008 May;57(5):519-23. Arerugi. 2008. PMID: 18520172 Review. Japanese. No abstract available.
• [Lowered effectiveness of immunotherapy for cypress pollinosis by using Japanese cedar pollen extract].

  Horiguchi S, Okamoto Y, Yonekura S, Okawa T, Kunii N, Yamamoto H, Sakurai D, Hanazawa T. Horiguchi S, et al. Arerugi. 2008 May;57(5):558-61. Arerugi. 2008. PMID: 18520178 Clinical Trial. Japanese.
• [Management and treatment of pollinosis in clinic].

  Okubo K, Gotoh M. Okubo K, et al. Nihon Rinsho. 2005 May;63 Suppl 5:145-50. Nihon Rinsho. 2005. PMID: 15954341 Review. Japanese. No abstract available.
• Severity assessment of Japanese cedar pollinosis using the practical guideline for the management of allergic rhinitis in Japan and the allergic rhinitis and its impact on asthma guideline.

  Gotoh M, Yuta A, Okano M, Ohta N, Matsubara A, Okubo K. Gotoh M, et al. Allergol Int. 2013 Jun;62(2):181-9. doi: 10.2332/allergolint.12-OA-0498. Epub 2013 Feb 25. Allergol Int. 2013. PMID: 23435559
• [Influence of the difference in the pollen count on medical costs in an allergen-specific immunotherapy for Japanese cedar pollinosis].

  Yuta A, Miyamoto Y, Hattori R, Ogihara H, Takeuchi K, Majima Y. Yuta A, et al. Arerugi. 2007 Nov;56(11):1366-71. Arerugi. 2007. PMID: 18059149 Japanese.